Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl J Cardella

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Transplantation|July 20, 2002
Anti-idiotypic antibodies from highly sensitized patients stimulate B cells to produce anti-HLA antibodiesNashrudeen Hack, Sarita Angra, Eva Friedman, et al.
Transplantation|November 30, 2005
Abnormal B-cell regulation in highly sensitized patients with sustained serum levels of antibody to HLA class I antigensNashrudeen Hack, Sarita Angra, Theresa L McKnight, et al.
Transplantation|July 23, 2009
Impact of deceased donor diabetes mellitus on kidney transplant outcomes: a propensity score-matched studyMufazzal Ahmad, Edward H Cole, Carl J Cardella, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 28, 2010
Delayed graft function and the risk of death with graft function in living donor kidney transplant recipientsRanjit Narayanan, Carl J Cardella, Daniel C Cattran, et al.
Diabetes Care|April 19, 2017
Use of Canagliflozin in Kidney Transplant Recipients for the Treatment of Type 2 Diabetes: A Case SeriesHarindra Rajasekeran, S Joseph Kim, Carl J Cardella, et al.
Journal of the American Society of Nephrology : JASN|October 31, 2009
Delayed graft function and the risk for death with a functioning graftShruti N Tapiawala, Kathryn J Tinckam, Carl J Cardella, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 26, 2010
The CLEAR study: a 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantationSita Gourishankar, Isabelle Houde, Paul A Keown, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2004
Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins)G V Ramesh Prasad, S Joseph Kim, Michael Huang, et al.
Transplantation Research|February 2, 2013
A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipientsEdward H Cole, G V Ramesh Prasad, Carl J Cardella, et al.
Transplantation|January 27, 2006
The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapyGang Chen, Hongtao Sun, Hongji Yang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Transplantation|July 20, 2002
Anti-idiotypic antibodies from highly sensitized patients stimulate B cells to produce anti-HLA antibodiesNashrudeen Hack, Sarita Angra, Eva Friedman, et al.
Transplantation|November 30, 2005
Abnormal B-cell regulation in highly sensitized patients with sustained serum levels of antibody to HLA class I antigensNashrudeen Hack, Sarita Angra, Theresa L McKnight, et al.
Transplantation|July 23, 2009
Impact of deceased donor diabetes mellitus on kidney transplant outcomes: a propensity score-matched studyMufazzal Ahmad, Edward H Cole, Carl J Cardella, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 28, 2010
Delayed graft function and the risk of death with graft function in living donor kidney transplant recipientsRanjit Narayanan, Carl J Cardella, Daniel C Cattran, et al.
Diabetes Care|April 19, 2017
Use of Canagliflozin in Kidney Transplant Recipients for the Treatment of Type 2 Diabetes: A Case SeriesHarindra Rajasekeran, S Joseph Kim, Carl J Cardella, et al.
Journal of the American Society of Nephrology : JASN|October 31, 2009
Delayed graft function and the risk for death with a functioning graftShruti N Tapiawala, Kathryn J Tinckam, Carl J Cardella, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 26, 2010
The CLEAR study: a 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantationSita Gourishankar, Isabelle Houde, Paul A Keown, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2004
Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins)G V Ramesh Prasad, S Joseph Kim, Michael Huang, et al.
Transplantation Research|February 2, 2013
A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipientsEdward H Cole, G V Ramesh Prasad, Carl J Cardella, et al.
Transplantation|January 27, 2006
The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapyGang Chen, Hongtao Sun, Hongji Yang, et al.
Pageof 2